Get alerts for new trials in your area by subscribing now
Eosinophilic esophagitis clinical trials test medicines that calm the immune response causing swelling in the esophagus, along with different ways to deliver treatment, from swallowed liquids to injections. Many trials measure success by looking directly at esophageal tissue under a microscope, not just by asking how someone feels.
Doctors used swallowed steroids off label for years before anything was formally approved for this specific condition. The first approved biologic reached patients in 2022, and the first approved oral formulation followed in 2024, both built on trials that measured actual tissue healing, not just symptom relief. Ongoing research is how treatment keeps expanding to younger children and different symptom patterns.
Both conditions involve the same type of immune overreaction, and research has found a strong statistical link between eosinophilic esophagitis and allergies to milk, egg, peanut, and seafood specifically. In one clinical trial, 97% of children being treated for eosinophilic esophagitis also had at least one other allergic condition, like asthma, eczema, or a food allergy.
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
Every study is reviewed by an independent ethics board before it can enroll anyone, and the specific risks, whether a trial involves medication, an elimination diet, or repeated endoscopies to check progress, are explained to you during informed consent, before you agree to anything.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.